ArticleNanoscale2026
Tailoring triplet energy transfer and Förster resonance energy transfer in boron dipyrromethene modified lanthanide doped upconversion nanohybrids.
Article in Nanoscale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tailoring the energy transfer (ET) processes, including the singlet energy transfer (SET) or triplet energy transfer (TET) process, in hybrid systems consisting of inorganic nanoparticles and organic molecules can offer a strategy for the design and synthesis of bright fluorescent probes for photodynamic therapy or photocatalytic applications. However, the weak absorption and low quantum yield of lanthanide doped upconversion nanoparticles (UCNPs) limited the performance of the molecule-UCNP hybrid system, and the complex mechanism of the ET process involving singlet and triplet excitons is yet to be fully understood. Here, we report on a strategy for the synthesis of boron dipyrromethene (BODIPY) modified UCNP nanohybrids to engineer the SET or TET processes, specifically 8-(4-carboxyphenyl)-3,5-(4-hydroxyl)styryl-1,7-tetramethyl-pyrromethene fluoroborate (BDP-1) and 8-(4-carboxyphenyl)-2,6-diiodo-3,5-(4-hydroxyl)styryl-1,7-tetramethyl-pyrromethene fluoroborate (IBDP-1). These nanohybrids exhibit enhanced upconversion performance with an 800-times increase in upconversion quantum yield (UCQY) and efficient singlet oxygen (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.